|
NT5C3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71307412699662E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70974345792274E-12 |
| Normal-vs-Stage2 |
2.0607999999922E-05 |
| Normal-vs-Stage3 |
5.36239999959776E-07 |
| Normal-vs-Stage4 |
2.52889999996508E-06 |
| Stage1-vs-Stage2 |
8.211000E-01 |
| Stage1-vs-Stage3 |
1.601170E-01 |
| Stage1-vs-Stage4 |
3.934200E-01 |
| Stage2-vs-Stage3 |
4.840000E-01 |
| Stage2-vs-Stage4 |
6.379400E-01 |
| Stage3-vs-Stage4 |
8.252000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06630038132494E-10 |
| Normal-vs-AfricanAmerican |
1.396440E-03 |
| Normal-vs-Asian |
1.60779944913259E-10 |
| Caucasian-vs-AfricanAmerican |
9.457000E-01 |
| Caucasian-vs-Asian |
1.048230E-02 |
| AfricanAmerican-vs-Asian |
8.910300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.34770039151545E-10 |
| Normal-vs-Female |
3.42947892306711E-13 |
| Male-vs-Female |
8.508200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.25208740545213E-12 |
| Normal-vs-Age(41-60Yrs) |
6.52530252054362E-11 |
| Normal-vs-Age(61-80Yrs) |
8.8917999963023E-08 |
| Normal-vs-Age(81-100Yrs) |
9.560200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.966400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.605400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.388470E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.930200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.276500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.801700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.322600E-01 |
| Classical-VS-Follicular |
3.422600E-03 |
| Classical-VS-Other |
6.505600E-01 |
| Classical-VS-Normal |
7.6930684045351E-12 |
| Tall-VS-Follicular |
1.838450E-02 |
| Tall-VS-Other |
3.916800E-01 |
| Tall-VS-Normal |
4.396400E-03 |
| Follicular-VS-Other |
2.672600E-01 |
| Follicular-VS-Normal |
5.67301761122962E-12 |
| Other-VS-Normal |
2.213200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1271873151818E-13 |
| Normal-vs-N1 |
1.610780E-04 |
| N0-vs-N1 |
4.396300E-02 |
|
|
